Recent progress of nuclear medicine evaluation of curative effect of <sup>223</sup>Ra dichloride treatment on castration- resistant prostate cancer and bone metastases

LOU Jingjing; LI Tongtong; LIU Xingdang; ZHANG Hong

doi:10.11889/j.0253-3219.2021.hjs.44.120301

您当前的位置：

首页 >

文章列表页 >

Recent progress of nuclear medicine evaluation of curative effect of ²²³Ra dichloride treatment on castration- resistant prostate cancer and bone metastases

NUCLEAR CHEMISTRY, RADIOCHEMISTRY, RADIOPHARMACEUTICALS AND NUCLEAR MEDICINE | 更新时间：2024-10-25

- Recent progress of nuclear medicine evaluation of curative effect of ²²³Ra dichloride treatment on castration- resistant prostate cancer and bone metastases
- “In 2020, China approved radium chloride injection for the treatment of castration resistant prostate cancer patients with bone metastases, becoming the world's first alpha particle targeted radiotherapy drug. At present, nuclear medicine technology has been widely used abroad to evaluate its efficacy, while it is still in the early stages of clinical application in China.”
- NUCLEAR TECHNIQUES Vol. 44, Issue 12, Article number: 120301(2021)
- 作者机构：
  
  1.浙江大学医学院附属第二医院核医学科杭州 310009
  2.复旦大学附属浦东医院核医学科上海 201399
  3.复旦大学附属华山医院核医学科上海 200040
  4.上海大学医学院上海 200444
- 作者简介：
  
  LOU Jingjing, female, born in 1977, graduated from Zhejiang University Medical School in 2007, focusing on nuclear medicine
  LIU Xingdang, E-mail: xingdliu@fudan.edu.cn
  ZHANG Hong, E-mail: hzhang21@zju.edu.cn
- 基金信息：
  
  The Pudong New Area Clinical Characteristic Discipline Project(PWYts2021-01);Pudong Hospital, Fudan University, College Level Project(YJYJRC202108;YJYJRC202101)
- DOI：10.11889/j.0253-3219.2021.hjs.44.120301
  CLC： TL99
- Received：11 October 2021，
  
  Revised：05 November 2021，
  
  Published：15 December 2021
- 稿件说明：
移动端阅览
楼菁菁,李童童,刘兴党等.²²³Ra对去势抵抗性前列腺癌骨转移疗效的核医学评估研究进展[J].核技术,2021,44(12):35-41.

LOU Jingjing,LI Tongtong,LIU Xingdang,et al.Recent progress of nuclear medicine evaluation of curative effect of ²²³Ra dichloride treatment on castration- resistant prostate cancer and bone metastases[J].NUCLEAR TECHNIQUES,2021,44(12):35-41.
楼菁菁,李童童,刘兴党等.²²³Ra对去势抵抗性前列腺癌骨转移疗效的核医学评估研究进展[J].核技术,2021,44(12):35-41. DOI： 10.11889/j.0253-3219.2021.hjs.44.120301.

LOU Jingjing,LI Tongtong,LIU Xingdang,et al.Recent progress of nuclear medicine evaluation of curative effect of ²²³Ra dichloride treatment on castration- resistant prostate cancer and bone metastases[J].NUCLEAR TECHNIQUES,2021,44(12):35-41. DOI： 10.11889/j.0253-3219.2021.hjs.44.120301.

Views

150

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

AI导读

AI问答

Address：2019 Jialuo Road, Jiading, Shanghai, China Postal code：201800
Tel：021-39194977 Email：LHB@sinap.ac.cn
Technical support is provided by Beijing Founder electronics co., LTD 沪ICP备05005479号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.
Total Visits：881293 Visits Today：11

⁰

Recent progress of nuclear medicine evaluation of curative effect of 223Ra dichloride treatment on castration- resistant prostate cancer and bone metastases

DOI：10.11889/j.0253-3219.2021.hjs.44.120301

Recent progress of nuclear medicine evaluation of curative effect of ²²³Ra dichloride treatment on castration- resistant prostate cancer and bone metastases